You are here

Leqvio

Novartis builds case for Leqvio with monotherapy data

Pharmaphorum

Wed, 08/28/24 - 11:29 am

clinical trials

Big Pharma’s most improved drugs: a new generation of blockbusters

Pharma Voice

Tue, 05/14/24 - 11:34 am

Novartis: Leqvio Provides Low-density Lipoprotein Cholesterol Reduction Beyond 6 Years Of Treatment

RTT News

Mon, 08/28/23 - 12:05 pm

LDL cholesterol

clinical trials

FDA approves label update of Novartis’ Leqvio to treat high LDL-C

Pharmaceutical Business Review

Tue, 07/11/23 - 10:20 am

Novartis pulls the plug on UK-based cardiovascular study

Endpoints

Wed, 03/22/23 - 09:11 pm

clinical trials

PCSK9 pipeline shows signs of saturation

EP Vantage

Tue, 09/27/22 - 10:21 am

Ionis Pharmaceuticals

PCSK9 inhibitors

Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits

Fierce Pharma

Wed, 02/2/22 - 11:10 am

JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn't plan to stop there, exec says

Fierce Pharma

Thu, 01/13/22 - 11:06 am

It Was To Be The Cholesterol Drug For The Masses. Novartis Changed That.

Forbes

Mon, 01/3/22 - 10:42 am

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

BioPharma Dive

Wed, 12/22/21 - 11:35 pm

Novartis plans unconventional sales strategy for new heart drug

Beckers Hospital Review

Mon, 11/22/21 - 10:29 pm

pharma marketing

Novartis finalizes deal to make new heart drug widely available in England

BioPharma Dive

Wed, 09/1/21 - 10:55 pm

Novartis looks to manufacturing investment to drive down cost of siRNA drug

Biopharma Reporter

Mon, 08/9/21 - 11:01 am

drug manufacturing

Novartis eyes New Year verdict from FDA on delayed Leqvio

Pharmaforum

Wed, 07/21/21 - 10:58 am

Novartis to make Leqvio for U.S. in Austria to overcome FDA delay

Reuters

Tue, 07/6/21 - 11:04 am

drug manufacturing

Novartis’s big wager on RNAi approaches the finish line

EP Vantage

Wed, 11/25/20 - 10:27 am